Track topics on Twitter Track topics that are important to you
Argyle Capital Management Inc. increased its position in shares of Teva Pharmaceutical Industries Limited by 8.8% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 56,852 shares of the company's stock after buying an additional 4,600 shares during the period.
Original Article: Argyle Capital Management Inc. Has $1.89 Million Position in Teva...NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...